Moallef S, Homayra F, Milloy MJ, Bird L, Nosyk B, Hayashi K High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics Subst Abus, 2021. PubMed

Morgan J, Schwartz C, Ferlatte O, Mnzisak C, Lachowsky N, Jollimore J, Hull M, Knight R Community-based participatory approaches to knowledge translation: HIV prevention case study of the Investigaytors program Arch Sex Behav, 2021. PubMed

Socías ME, Dong H, Wood E, Nolan S, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy and overdose risk during a community-wide overdose epidemic in a Canadian setting Am J Prev Med, 2021. PubMed

Dong H, Hayashi K, Fairbairn N, Milloy MJ, DeBeck K, Wood E, Kerr T Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting Addict Behav, 2021. PubMed

Socías ME, Nolan S Can extended-release injectable medications help curb United States and Canada's opioid overdose epidemic? J Addict Med, 2021. PubMed

Bach P, Ti L Hepatitis C and stimulant use disorder: challenges and opportunities Clin Infect Dis, 2020. PubMed

Long V, Arredondo J, Ti L, Grant C, DeBeck K, Milloy MJ, Lysyshyn M, Wood E, Kerr T, Hayashi K Factors associated with drug checking service utilization among people who use drugs in a Canadian setting Harm Reduct J, 2020. PubMed

Ryan A, Sereda A, Fairbairn N Measures to support a safer drug supply CMAJ, 2020. PubMed

Beaulieu T, Barbic S, Milloy MJ, Puri N, Hayashi K, Ti L PMH24 Factors associated with receiving integrated care among people with concurrent opioid use disorder and mental illness in a Canadian setting Value Health, 2020. Link

Kennedy MC, Milloy MJ, Hayashi K, Holliday E, Wood E, Kerr T Assisted injection within supervised injection services: uptake and client characteristics among people who require help injecting in a Canadian setting Int J Drug Policy, 2020. PubMed